Example: Heart Attack

Search clinical trials for: Valrubicin

Total 9 results

NCT01316874

Completed

Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)

Conditions: Carcinoma in Situ; Bladder Cancer
NCT01606345

Completed

Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma

Conditions: Urothelial Carcinoma
NCT01310803

Terminated

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Conditions: Carcinoma in Situ; Transitional Cell Carcinoma; Non-muscle Invasive Bladder Cancer
NCT00003129

Completed

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Conditions: Bladder Cancer
NCT00003725

Unknown status

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Conditions: Bladder Cancer
NCT00003759

Completed

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Conditions: Bladder Cancer
NCT01314664

Terminated

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Conditions: Bladder Cancer; CIS
NCT01304173

Completed

Retrospective Chart Review of Valstar

Conditions: Carcinoma in Situ of Bladder
NCT01438112

Terminated

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

Conditions: Transitional Cell Carcinoma; Bladder Cancer; Carcinoma in Situ; Carcinoma in Situ Concurrent With Papillary Tumors